<DOC>
	<DOCNO>NCT01362673</DOCNO>
	<brief_summary>This Phase 1 study first clinical trial Japanese subject . This study design evaluate single- multiple-dose pharmacokinetics , safety tolerability PF-04171327 oral tablet healthy adult Japanese Western subject fast fed condition .</brief_summary>
	<brief_title>PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject non childbearing potential age 18 55 year . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 45 kg ( 99 lb ) . Japanese subject four Japanese grandparent born Japan . Confirmed fast glucose 100 mg/dL Screening Day 0 Cohort A B. Corticosteroid use 5 mg prednisone equivalent per day 6 week . Evidence history clinically significant hematological ( include anemia ) , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>food effect</keyword>
	<keyword>Healthy Japanese</keyword>
	<keyword>rheumatoid arthritis</keyword>
</DOC>